SAN DIEGO–(BUSINESS WIRE)–$AGL #Agilon—Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquiredSAN DIEGO–(BUSINESS WIRE)–$AGL #Agilon—Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired

Investor Notice: Robbins LLP Informs Investors of the Agilon Health, Inc. Securities Class Action

2026/01/01 06:15
3분 읽기
이 콘텐츠에 대한 의견이나 우려 사항이 있으시면 crypto.news@mexc.com으로 연락주시기 바랍니다

SAN DIEGO–(BUSINESS WIRE)–$AGL #Agilon—Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired agilon health, inc. (NYSE: AGL) securities between February 26, 2025 and August 4, 2025. Agilon describes itself as the “trusted partner empowering physicians to transform health care in our communities.”

For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003.

The Allegations: Robbins LLP is Investigating Allegations that Agilon Health, Inc. (AGL) Misled Investors Regarding its Business Prospects

According to the complaint, defendants failed to disclose that they recklessly issued guidance for 2025 that they knew or should have known was not going to be achieved, given material industry headwinds of which they were aware, and materially overstated the immediate positive financial impact from “strategic actions” taken by agilon to reduce risk.

On August 4, 2025, agilon issued a press release announcing that Steven Sell had stepped down as President, CEO and a Director of the Board. Plaintiff alleges that the Company’s form 8-K filed with the SEC stated that “Mr. Sell’s departure was a termination without ’cause’ under Mr. Sell’s employment agreement[.]” The complaint further alleges that on August 4, 2025, agilon issued disappointing financial results. On this news, the price of the Company’s stock fell over 50%, to close at $0.8801 on August 5, 2025.

What Now: You may be eligible to participate in the class action against agilon health, inc. Shareholders who wish to serve as lead plaintiff for the class should contact Robbins LLP. The lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery. If you choose to take no action, you can remain an absent class member. For more information, click here.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

About Robbins LLP: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002.

To be notified if a class action against agilon health, inc. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Aaron Dumas, Jr.

Robbins LLP

5060 Shoreham Pl., Ste. 300

San Diego, CA 92122

adumas@robbinsllp.com
(800) 350-6003

www.robbinsllp.com

시장 기회
4 로고
4 가격(4)
$0.016109
$0.016109$0.016109
-2.81%
USD
4 (4) 실시간 가격 차트
면책 조항: 본 사이트에 재게시된 글들은 공개 플랫폼에서 가져온 것으로 정보 제공 목적으로만 제공됩니다. 이는 반드시 MEXC의 견해를 반영하는 것은 아닙니다. 모든 권리는 원저자에게 있습니다. 제3자의 권리를 침해하는 콘텐츠가 있다고 판단될 경우, crypto.news@mexc.com으로 연락하여 삭제 요청을 해주시기 바랍니다. MEXC는 콘텐츠의 정확성, 완전성 또는 시의적절성에 대해 어떠한 보증도 하지 않으며, 제공된 정보에 기반하여 취해진 어떠한 조치에 대해서도 책임을 지지 않습니다. 본 콘텐츠는 금융, 법률 또는 기타 전문적인 조언을 구성하지 않으며, MEXC의 추천이나 보증으로 간주되어서는 안 됩니다.

$30,000 in PRL + 15,000 USDT

$30,000 in PRL + 15,000 USDT$30,000 in PRL + 15,000 USDT

Deposit & trade PRL to boost your rewards!